Not available
Quote | Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest (NYSE:EVT)
Last: | $22.40 |
---|---|
Change Percent: | -0.4% |
Open: | $22.5 |
Close: | $22.40 |
High: | $22.555 |
Low: | $22.38 |
Volume: | 74,431 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest (NYSE:EVT)
COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS ...
HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as prov...
Message Board Posts | Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest (NYSE:EVT)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Eaton Vance Tax Advantaged Dividend (EVT) Headlines Eaton Vance Tax-Advantaged | Stock_Tracker | investorshangout | 03/14/2014 6:24:15 PM |
chartguy89: EVT Stock Charts Last: +0.26 $EVT 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 1:53:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
EVT Stock Symbol:
NYSE Market:
COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS ...
HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as prov...
HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced the appointment of Aurélie Dalbiez as the Company's new Chief People Officer ("CPO"), effective 15 June 2024. Aurélie will be joining E...